Maria Rita Bongiorno Selected Research

Maria Rita Bongiorno Research Topics

Disease

7	Psoriasis (Pustulosis Palmaris et Plantaris) 08/2022 - 01/2007
7	Neoplasms (Cancer) 01/2022 - 03/2002
3	Atopic Dermatitis (Atopic Eczema) 04/2023 - 01/2021
3	Pemphigus (Pemphigus Vulgaris) 02/2015 - 06/2010
2	Infections 08/2022 - 06/2022
2	Disease Progression 01/2022 - 06/2010
2	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 08/2021
2	Melanoma (Melanoma, Malignant) 01/2022 - 06/2006
2	Neoplasm Metastasis (Metastasis) 08/2021 - 01/2021
2	COVID-19 01/2021 - 01/2021
2	Cytokine Release Syndrome 01/2021 - 11/2008
1	Latent Tuberculosis 08/2022
1	Tuberculosis (Tuberculoses) 08/2022
1	Hepatitis C 06/2022
1	Virus Diseases (Viral Diseases) 06/2022
1	Hepatitis 06/2022
1	Hepatitis B 06/2022
1	Inflammation (Inflammations) 04/2022
1	Skin Neoplasms (Skin Cancer) 01/2022
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2022
1	Multiple Organ Failure (MODS) 01/2021
1	Actinic Keratosis 11/2020
1	Nail Diseases (Nail Disease) 01/2018
1	Chronic Urticaria 12/2016
1	Hypertension (High Blood Pressure) 03/2013
1	Allergic Contact Dermatitis 11/2012
1	Urticaria (Hives) 11/2012
1	Headache (Headaches) 06/2010
1	Exfoliative Dermatitis (Erythroderma) 06/2010
1	Alkaptonuric ochronosis 02/2005

Drug/Important Bio-Agent (IBA)

4	Adrenal Cortex Hormones (Corticosteroids)IBA 08/2022 - 06/2010
3	secukinumabIBA 08/2022 - 01/2018
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 06/2006
3	Mycophenolic Acid (Cellcept)FDA LinkGeneric 02/2015 - 06/2010
2	dupilumabIBA 04/2023 - 01/2021
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2022 - 06/2022
2	Phosphotransferases (Kinase)IBA 01/2022 - 01/2021
2	CytokinesIBA 01/2022 - 11/2008
1	InterleukinsIBA 08/2022
1	RNA (Ribonucleic Acid)IBA 06/2022
1	DNA (Deoxyribonucleic Acid)IBA 06/2022
1	Transaminases (Aminotransferases)IBA 06/2022
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 06/2022
1	Keratins (Keratin)IBA 04/2022
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2022
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022
1	human ERBB2 proteinIBA 01/2022
1	ErbB Receptors (EGF Receptor)IBA 01/2022
1	nobiletinIBA 08/2021
1	xanthohumolIBA 08/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	Nerve Growth Factors (Neurotrophins)IBA 01/2021
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2021
1	Nerve Growth Factor (NGF)IBA 01/2021
1	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 01/2020
1	Omalizumab (Xolair)FDA Link 12/2016
1	Triglycerides (Triacylglycerol)IBA 03/2013
1	LipidsIBA 03/2013
1	rosin (pine resin)FDA Link 11/2012
1	AutoantibodiesIBA 02/2011
1	Immunosuppressive Agents (Immunosuppressants)IBA 02/2011
1	Blood Glucose (Blood Sugar)IBA 06/2010
1	Prednisone (Sone)FDA LinkGeneric 06/2010
1	Azathioprine (Imuran)FDA LinkGeneric 06/2010
1	Technetium Tc 99m Sestamibi (Cardiolite)FDA LinkGeneric 06/2010
1	betamethasone-17,21-dipropionate (betamethasone dipropionate)FDA LinkGeneric 01/2007
1	calcipotriol drug combination betamethasone dipropionate FDA Link 01/2007
1	calcipotriene (calcipotriol)FDA LinkGeneric 01/2007
1	hydroquinone (Esoterica)FDA Link 02/2005
1	Melanins (Melanin)IBA 03/2002

Therapy/Procedure

13	Therapeutics 08/2022 - 06/2010
3	Biological Therapy 08/2022 - 01/2019
3	Drug Therapy (Chemotherapy) 08/2021 - 01/2020
2	Phototherapy (Light Therapy) 08/2022 - 01/2021
1	Chemoprevention 08/2022
1	Aftercare (After-Treatment) 11/2020